Dexcom adds COO to CFO Blackford’s title | Personnel Moves, September 19, 2019

Dexcom (NSDQ:DXCM) this week added the COO role to CFO Quentin Blackford’s title.

Blackford is now in charge of Dexcom’s global supply chain, manufacturing operations and expansion into new markets, the San Diego-based company said. He’s been CFO of the continuous glucose monitor maker since 2017, when he left the chief finance spot at NuVasive (NSDQ:NUVA).

“We believe we are on the cusp of tremendous opportunities that will require discipline across our financial investments, resource allocation and business processes,” president & CEO Kevin Sayer said in prepared remarks. “In light of this, we are expanding Quentin’s role to include oversight of global manufacturing operations, supply chain management and expansion into new markets. We believe this expanded role will allow for better coordination across key business units that are critical to the realization of these opportunities.”

Cerner lures Medtronic’s Johnson for chief marketing role
Cerner (NSDQ:CERN) this week lured Darrell Johnson away from Medtronic (NYSE:MDT) to be its first chief marketing officer.

Johnson, a 20-year veteran of the medtech industry, was the vice president of corporate data strategy at Medtronic and previously worked at GE Healthcare.

“I’m pleased to welcome Darrell to our team,” said Brent Shafer, chairman and CEO, Cerner. “His experience in market innovation, business transformation and global brand positioning makes him a perfect fit for this moment in Cerner’s history. Earlier this year, we introduced a new operating model focused on our clients’ success and we are in the early stages of a transformation that is driving faster, more scalable innovation. Darrell will provide critical leadership as the company pursues new growth strategies and introduces new solutions to the market.”
Read More

Stereotaxis looks to finance VP Peery for new CFO
Stereotaxis (NSDQ:STXS) promoted finance VP Kimberly Peery to replace CFO Martin Stammer, effective Sept. 30.

“I appreciate the confidence placed in me by the Stereotaxis board of directors and look forward to becoming CFO in this exciting period for Stereotaxis,” said Peery, who joined the companyin 2003.

“I have really enjoyed my time at Stereotaxis and firmly believe in the future of the Company,” said Martin Stammer. “I have the utmost confidence in Kim and her team and look forward to seeing them achieve many additional milestones,” added Stammer, who’s slated to join a St. Louis professional services firm as CFO.

“I appreciate Marty’s contributions to Stereotaxis over many years and wish him well in his future endeavors. He leaves us in a strong position following our recently completed financing and uplisting to the NYSE American. I am excited to work with Kim and congratulate her on her new leadership role,” chairman & CEO David Fischel said.
Read More

Zimmer Biomet taps Endo accounting chief Nichol for CAO
Zimmer Biomet (NYSE:ZBH) this week named Carrie Nichol as VP, controller & chief accounting officer, effective Oct. 1, replacing interim CAO Suketu Upadhyay, who will stay on as CFO.

Nichol was CAO at pharma giant Endo International (NSDQ:ENDP).Read More

Microdermics names ex-Edwards CMO Duhay as CEO
Microdermics named Dr. Francis Duhay, the former chief medical officer at Edwards Lifesciences (NYSE:EW), to be its new CEO.

“Francis is a prominent and well-respected industry veteran and physician and has extensive experience that spans all aspects of the medical device industry, from running medical device businesses, to driving successful clinical programs, to performing medical procedures himself,” board member Lana Janes said in prepared remarks. “His expertise and insights will enable us to speed the development process for our unique platform technology that has the potential to both derive insights from the skin and deliver therapy.”

“I am intrigued by the duel opportunity inherent in the Microdermics microsensor platform,” Duhay added. “Having been involved in emerging medical businesses for more than 20 years and directly with patients long before that, the promise of a technology that makes monitoring a patient’s health condition and managing it easier and faster is the future. I look forward to bringing my experience to bear to drive the technology forward to success.”
Read More